Drug Safety Are We Making Progress?

被引：0
作者：
Luepker, Russell V. [1 ]
机构：
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA
来源：
ARCHIVES OF INTERNAL MEDICINE | 2010年 / 170卷 / 02期
关键词：
CLINICAL-TRIALS;
D O I：
10.1001/archinternmed.2009.496
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [31] Food and drug administration's critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies
    Mahajan, Rajiv
    Gupta, Kapil
    [J]. JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2010, 2 (04): : 307 - 313
  • [32] Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are?
    Kumbhar, Popat S.
    Chavan, Revati
    Darekar, Snehal
    Kolekar, Kaustubh
    Sequeira, Anvitha
    Vishwas, Sukriti
    Gupta, Guarav
    Paudel, Keshav Raj
    Singh, Sachin Kumar
    Dua, Kamal
    Disouza, John
    Patravale, Vandana
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, : 3213 - 3240
  • [33] Making Medicine Precise and Personalized: What Can We Learn from the Past?
    Taylor, Anne L.
    [J]. CIRCULATION-HEART FAILURE, 2016, 9 (02) : 1 - 3
  • [34] Graft-versus-host disease: why have we not made more progress?
    Jaglowski, Samantha M.
    Devine, Steven M.
    [J]. CURRENT OPINION IN HEMATOLOGY, 2014, 21 (02) : 141 - 147
  • [35] Have we made progress in the management of chronic graft-vs-host disease?
    Lee, Stephanie J.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2010, 23 (04) : 529 - 535
  • [36] Can we design and replicate clinical trials with a multiple drug focus
    O'Brien, CP
    Lynch, KG
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (02) : 135 - 137
  • [37] Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
    Mohammad Sadeghi, Hosna
    Adeli, Ida
    Mousavi, Taraneh
    Daniali, Marzieh
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    [J]. LIFE-BASEL, 2021, 11 (08):
  • [38] Likelihood ratio based tests for longitudinal drug safety data
    Huang, Lan
    Zalkikar, Jyoti
    Tiwari, Ram
    [J]. STATISTICS IN MEDICINE, 2014, 33 (14) : 2408 - 2424
  • [39] Observations from the OMERACT Drug Safety Summit, May 2008
    Simon, Lee S.
    Strand, C. Vibeke
    Boers, Maarten
    Brooks, Peter M.
    Henry, David
    Tugwell, Peter S.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (09) : 2110 - 2113
  • [40] Drug safety in thalassemia: lessons from the present and directions for the future
    Grech, Laura
    Sultana, Janet
    Borg, Karen
    Borg, Joseph
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (08) : 937 - 947
12345